Dear Readers,
More than any sector, healthcare has come under particular scrutiny in recent years. The reasons are almost too obvious to state. The pandemic; soaring costs; difficulties in the supply chain for key medicines – all have propelled healthcare to the headlines on both sides of the Atlantic, and beyond.
The vagaries of medical research; the difficulties inherent to insurance; and the intrinsic risks based on investment into medical research all feed into this concern.
As Andrew Stiv
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.139.240.142
Please verify email or join us to access premium content!